No Data
No Data
Peering Into TG Therapeutics's Recent Short Interest
TG Therapeutics's (NYSE:TGTX) short percent of float has fallen 6.31% since its last report. The company recently reported that it has 35.71 million shares sold short, which is 25.55% of all regular s
TG Therapeutics Under Pressure: Navigating the Perils of Government Contracts and Compliance Hurdles
TG Therapeutics | 10-Q: Quarterly report
New Forecasts: Here's What Analysts Think The Future Holds For TG Therapeutics, Inc. (NASDAQ:TGTX)
Shareholders in TG Therapeutics, Inc. (NASDAQ:TGTX) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The analysts greatly increased their
Earnings Call Summary | TG Therapeutics(TGTX.US) Q1 2024 Earnings Conference
The following is a summary of the TG Therapeutics, Inc. (TGTX) Q1 2024 Earnings Call Transcript:Financial Performance:TG Therapeutics reported total revenue for Q1 2024 of $63.5 million, with U.S. Bri
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
No Data